Diagnosis and management of adrenal cortical carcinoma
- PMID: 17239320
- DOI: 10.1007/s11934-007-0024-6
Diagnosis and management of adrenal cortical carcinoma
Abstract
Adrenal cortical carcinoma is a relatively uncommon malignancy that represents a significant clinical challenge for the development of optimal treatment strategies. Historically, successful treatment has relied upon rapid identification of the lesion, accurate staging with diagnostic imaging, and complete surgical extirpation. Although the framework of a successful treatment paradigm still relies on these steps, advances in diagnostic imaging have led to increased accuracy in diagnosis, and advances in laparoscopic surgical technique have served to reduce morbidity for patients facing treatment. This review focuses on a discussion of advances in modalities for the diagnosis and treatment of adrenal cortical carcinoma amenable to curative therapy. Patients that present with metastatic or locally advanced disease generally are treated with mitotane-based chemotherapy with or without the addition of cytotoxic drugs. Contemporary results of this treatment approach are presented in this review as well as a discussion of further directions for the treatment of patients with advanced disease.
Similar articles
-
Adrenocortical carcinoma.Endocrinol Metab Clin North Am. 2015 Jun;44(2):411-34. doi: 10.1016/j.ecl.2015.03.001. Endocrinol Metab Clin North Am. 2015. PMID: 26038209 Review.
-
Diagnosis, treatment and outcome of adrenocortical cancer.Br J Surg. 2015 Mar;102(4):291-306. doi: 10.1002/bjs.9743. Br J Surg. 2015. PMID: 25689291 Review.
-
Contemporary management of adrenocortical carcinoma.Eur Urol. 2011 Nov;60(5):1055-65. doi: 10.1016/j.eururo.2011.07.062. Epub 2011 Aug 4. Eur Urol. 2011. PMID: 21831516 Review.
-
Future directions in the diagnosis and medical treatment of adrenocortical carcinoma.Endocr Relat Cancer. 2016 Jan;23(1):R43-69. doi: 10.1530/ERC-15-0452. Epub 2015 Oct 16. Endocr Relat Cancer. 2016. PMID: 26475053 Review.
-
Treatment of Adrenocortical Carcinoma.Surg Pathol Clin. 2019 Dec;12(4):997-1006. doi: 10.1016/j.path.2019.08.010. Epub 2019 Sep 27. Surg Pathol Clin. 2019. PMID: 31672303 Review.
Cited by
-
Clinicopathological Features Associated With the Prognosis of Patients With Adrenal Cortical Carcinoma: Usefulness of the Ki-67 Index.Medicine (Baltimore). 2016 May;95(21):e3736. doi: 10.1097/MD.0000000000003736. Medicine (Baltimore). 2016. PMID: 27227935 Free PMC article.